PLOS One · Nov 18, 2026
The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences
By Chen S, Cai M, Song Y et al.
Introduction: This study focuses on the impact and future trends of COVID-19 on the burden of Alzheimer’s disease and related dementias (ADRD), analyzing multidimensional differences in the burden of disease for ADRD in 204 countries between 1990 and 2021. Methods: Using Global Burden of Disease (GBD) data (1990–2021), we analyzed Alzheimer’s disease and related dementias (ADRD) prevalence and burden across 204 countries, stratified by sex and age. Joinpoint regression identified temporal inflection points in incidence, mortality, disability-adjusted life years (DALYs), and years of life lost (YLL), while age-standardized rates and estimated annual percentage changes assessed global burden trends. We further evaluated ADRD-associated risk factors, quantified COVID-19’s impact through excess burden attribution models, and projected incidence trajectories to 2050 via Bayesian Age-Period-Cohort analysis. Results: Global Burden of Disease analyses (1990–2021) show 2021 ADRD incidence of 119.76/100,000, with 450.98 DALYs and 309.03 YLL/100,000. Post-2019 COVID-19 onset, all SDI regions except high-SDI exhibited significant ADRD incidence increases (P < 0.05). Women ≥55 years had the highest burden, with behavioral risks contributing most to DALYs (2021). China showed the steepest ADRD incidence rise (1990–2021), accelerating post-COVID-19, contrasting declines in Denmark and Australia. COVID-19 ASIR (2020) and ADRD ASPR (2020) had a standardized path coefficient of 0.237 (P < 0.05); COVID-19 ASIR (2020) and ADRD ASPR (2021) covariance reached 0.275 (P < 0.05). Projections suggest declining ASIR for ages 40–79 but rising ASIR for ≥80 by 2050. Conclusion: To effectively mitigate the ongoing rise in ADRD, particularly among older women and middle-high SDI populations, targeted prevention and control strategies must be developed, with careful consideration of socioeconomic factors and the long-term impacts of COVID-19.
doi.org/10.1371/journal.pone.0359947Open accessPubMed 43050399Populations